Discover 3,073 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,073
O2 Consumption and Heart Rate Response to Battle Rope Exercise Protocol Versus UE Arm Bike Test in Adults With SCI
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 0
Code: NCT02140255
Phase1, Phase2, Recruiting
A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
for
Open-angle Glaucoma, Ocular Hypertension
Location: Houston TX, Morrow GA, Newport Beach CA, Bakersfield CA
Sponsor: Amneal Pharmaceuticals, LLC
Sex: All
Age: 18+
Code: NCT06267274
Phase1, Recruiting
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition
for
Primary Immune Regulatory Disorder,
Location: Houston TX, Atlanta GA, Milwaukee WI, Philadelphia PA,
Sponsor: Joseph Oved
Sex: All
Age: 0+
Code: NCT05787574
Phase2, Recruiting
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
for
Crohn's Disease (CD)
Location: Houston TX, Atlanta GA, Park Ridge IL, Roanoke VA,
Sponsor: Takeda
Sex: All
Age: 2 - 17
Code: NCT04779320
Phase3, Recruiting
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
for
Type 2 Diabetes
Location: Houston TX, Dallas TX, Jackson MS, Little Rock AR,
Sponsor: Eli Lilly and Company
Sex: All
Age: 10 - 17
Code: NCT06739122
Phase3, Recruiting
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
for
High Grade Glioma, Diffuse Intrinsic Pontine Glioma